Indian research & development
organisation offers the technology of Infectious Bovine
Rhinotracheitis (IBR)- vaccine. IBR is an economically
important disease which is common in cattle and is caused
by Bovine Herpes Virus - 1 (BHV 1). If cattle get infected
with this disease, it may cause severe losses to the
farmers. The IBR vaccine is an oil based vaccine and
therefore safe. It produces quick, long lasting immunity
to the vaccinated animal. The cost of the vaccine with
imported source is approx US$ 1.0 per dose. The product
to be produced with this technology is expected to be
substantially low dose.
Area of Application:
Pharmaceutical industry, veterinary medicine: The vaccine
can protect cattle from various clinical syndromes and
diseases caused by this virus such as respiratory disease,
genital disorders, infectious pustular vulvovaginitis
in heifers, cows, she-buffaloes and infectious pustular
balanoposthitis in bulls, abortion infections of eyes
and in nervous system, digestive system, skin, etc.
Advantages: At
present only one firm is manufacturing IBR vaccine in
India under the licence from the organistion and till
recently the product was mostly imported from Europe,
USA etc. Moreover, since the disease is caused by a
virus (BHV1), hence there is no therapeutic control
of the disease except preventive vaccination.
Development Status:
Commercialised , Pilot Plant
Contact:
Asian and Pacific Centre for Transfer
of Technology
APCTT Building
C-2 Qutab Institutional Area
P.O.Box - 4575
New Delhi - 110 016
Tel : 91-11-26966509
Fax : 91-11-26856274
